SOP Number Insert Number SOP Title: Informed Consent

STANDARD OPERATING PROCEDURE Insert Department
SOP No: Insert No.

SOP Title: Informed Consent
SOP Number Insert Number

SOP Title Informed Consent
NAME TITLE SIGNATURE DATE

Author
Reviewer
Authoriser
Effective Date:
Review Date:
Page 1 of 5
Adapted from CTRG Template SOP Version 1 dated 31st May 2006
Original Author: E. Chick
© Copyright: The University of Oxford 2006
SOP No: Insert No.
This SOP template has been written as an example which can be adapted for use in any
department conducting clinical research where there are no SOPs in place. The contents of the
SOP should be reviewed in conjunction with the procedures which take place within the
department and the text should be altered accordingly.
Delete highlighted text before finalising the document.
1. PURPOSE
The purpose of this Standard Operating Procedure (SOP) is to describe the standard
procedures to be followed when obtaining Informed Consent from subjects involved in
clinical studies sponsored by the Oxford Radcliffe Hospitals (ORH) NHS Trust
2. INTRODUCTION
Informed consent is the process by which a competent subject voluntarily confirms his or
her willingness to participate in a particular study having comprehended all aspects of the
study. For clinical trials, performing any research related procedure on someone without
first obtaining their informed consent, is in breach of The Medicines for Human Use
(Clinical Trials) Regulations 2004/2006, which were developed according to the European
Directive on Good Clinical Practice in Clinical Trials (2001)
For other research, the Research Governance Framework for Health and Social Care
(second edition 2005) states that ‘Most studies involving individuals must have appropriate
arrangements for obtaining consent’.
Written information must be provided on subject information sheets and verbal information
is provided by the investigator.
3. SCOPE
This SOP applies to clinical research where the ORH NHS Trust has accepted the role of
‘Sponsor’, in the INSERT NAME department/ for the INSERT NAME/NUMBER trial.*
* delete as appropriate
This SOP does not apply to commercially sponsored research or research sponsored by
an external non-commercial organisation.
4. RESPONSIBILITIES
4.1 Investigator or delegate

Any person who will play a role in the consent process must have a comprehensive
understanding of the study, potential treatment toxicities (in the case of clinical trials), other
safety implications and the associated disease area. They should be qualified by
experience and should have received appropriate training for this study. All training should
be documented.
The delegation of Informed Consent to an appropriate, suitably qualified member of the research
Page 2 of 5
SOP No: Insert No.
team should be considered on a trial-by-trial basis, taking account of local circumstances and in
accordance with ICH Good Clinical Practice Guidelines. An effective line of communication
should always be maintained back to the Principal Investigator who is ultimately responsible for
the subject’s care.
Delegation of responsibility for aspects of the informed consent process should be

documented on the appropriate form which should be filed in the Trial Master File (TMF).
It is the responsibility of the investigator or delegate to ensure that subjects have fully
understood what they are consenting to.
5. PROCEDURE
5.1 Preparation of Subject Information Sheet and Informed Consent Form
Detailed guidelines for preparation of information sheets and consent forms can be found
on the NRES website at:
http://www.nres.npsa.nhs.uk/applications/guidance/consent-guidance-and-forms/
5.2 Informing the subject
The subject must sign the informed consent form prior to any study related procedures
being carried out. The informed consent process should continue throughout the study,
keeping subjects informed of any protocol amendments or new information which the
investigator feels is relevant to them.
Information should be provided to potential study subjects in both oral and written form.
The language used in both oral and written information about the study should be clear
and concise and described in layman’s terms.
The subject should be given ample time to read the information sheet. This should always
be the most recent version which has been approved by the ethics committee. Ideally they
should have a few days to discuss the information with family and friends etc.
The subject should have an interview with the investigator or another member of the team
in which they are given the opportunity to understand the objectives, risks and
inconveniences of the trial and the conditions under which it is to be conducted. They
should then have an opportunity to ask questions of the investigator or delegated
representative.
Neither the investigator nor any member of the clinical research team should coerce or
unduly influence a subject to participate or to continue to participate in the trial. It should
be made clear to the subject that declining to take part in the study will not affect their
future care or treatment and that they are free to withdraw from future involvement with the
study at any stage without providing a reason.
Page 3 of 5
SOP No: Insert No.
If changes are made to the information sheet and/or consent form during the study, which
are considered relevant to subjects who have signed the previous version and are still
participating in the study, they should be asked to also sign the new version to ensure that
they are willing to continue under the new conditions.
5.3 Recording Informed Consent

When the person taking consent is satisfied that the subject has been fully informed and
understands what study participation entails, the consent form should be signed and dated
by the subject and the authorised person who has conducted the discussion. All names
should be printed clearly beneath the signatures.
The process of obtaining informed consent should be documented in the subjects medical
records (if applicable) detailing the study title and date of consent.
Two copies of the signed and dated consent form should be made. The original should be
filed in the relevant section of the TMF, a copy should be given to the subject and a copy
should be filed in the subject’s medical records (if applicable). Copies may also be
required by the co-ordinating centre, in a multi-centre study.
Copies of consent forms signed by subjects who do not go forward to participate in the
study should also be kept in the TMF and not discarded.
6. FORMS/TEMPLATES TO BE USED
Where Forms/Templates are referenced in the text, the numbers and titles are listed under
this section.
7. INTERNAL AND EXTERNAL REFERENCES

This section is used to list all controlled internal references (e.g. SOPs) and external
references referred to within the text of the SOP only.
7.1 Internal References
7.2 External References

ICH Harmonised Tripartite Guideline for Good Clinical Practice.
Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the
approximation of the laws, regulations and administrative provisions of the Member States
relating to the implementation of good clinical practice in the conduct of medicinal products
for human use.
Page 4 of 5
SOP No: Insert No.
Research Governance Framework for Health and Social Care (2nd Edition 2005)
The Medicines for Human Use (Clinical Trials) Regulations 2004
8. CHANGE HISTORY
Where the SOP is the initial version:
 SOP No: Record the SOP and version number
 Effective Date: Record effective date of the SOP or “see page 1”
 Significant Changes: State, “Initial version” or “new SOP”
 Previous SOP no.: State “NA”.
Where replacing a previous SOP:
 SOP No: Record the SOP and new version number
 Effective Date: Record effective date of the SOP or “see page 1”
 Significant Changes: Record the main changes from previous SOP
 Previous SOP no.: Record SOP and previous version number
Effective Previous
SOP no. Significant Changes
Date SOP no.
Page 5 of 5

SOP Number Insert Number SOP Title: Informed Consent

Uploaded by

Copyright:

Available Formats

SOP Number Insert Number SOP Title: Informed Consent

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

SOP Number Insert Number SOP Title: Informed Consent

Uploaded by

Copyright:

Available Formats

STANDARD OPERATING PROCEDURE Insert Department

SOP No: Insert No.

SOP Number Insert Number

NAME TITLE SIGNATURE DATE

Delete highlighted text before finalising the document.

4.1 Investigator or delegate

Delegation of responsibility for aspects of the informed consent process should be

5.1 Preparation of Subject Information Sheet and Informed Consent Form

5.2 Informing the subject

5.3 Recording Informed Consent

7. INTERNAL AND EXTERNAL REFERENCES

7.1 Internal References

7.2 External References

You might also like